subject: UMLS:C4745171


subject: UMLS:C4745171

subject_name: mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)

tested_intervention: unsure


subject: UMLS:C4745171

object_name: urothelial carcinoma


subject: UMLS:C4745171

object_name: transitional cell carcinoma


subject: UMLS:C4745171

object_name: non-small cell lung carcinoma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: gastroesophageal adenocarcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:15365

subject_name: Aspirin

object_name: Primary hypercholesterolemia


subject: CHEBI:15365

object_name: hyperlipidemia, familial combined, LPL related


subject: CHEBI:15365

object_name: Mixed hyperlipidemia (disorder)


subject: CHEBI:15365

object_name: Mixed Hyperlipidemia


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:37941


subject: CHEBI:37941


subject: CHEBI:37941


subject: CHEBI:135942

subject_name: Laropiprant


subject: CHEBI:135942


subject: CHEBI:135942


subject: CHEBI:135942


subject: PUBCHEM.COMPOUND:10216733

subject_name: DIASTEREOMER 2


subject: PUBCHEM.COMPOUND:10216733


subject: PUBCHEM.COMPOUND:10216733


subject: PUBCHEM.COMPOUND:10216733


subject: CHEBI:15940

subject_name: Niacin


subject: CHEBI:15940


subject: CHEBI:15940


subject: CHEBI:15940


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: CHEBI:17154


subject: CHEBI:17154


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Post-Operative Pain


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: PUBCHEM.COMPOUND:156464216

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:156464216

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5785492

subject_name: BTK Degrader NX-5948


subject: UMLS:C5785492


subject: CHEBI:17987

subject_name: Benzyl alcohol

object_name: Pediculus humanus capitis infestation

tested_intervention: yes


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: pancreatic adenocarcinoma


subject: UNII:6XC1PAD3KF

object_name: Pancreatic carcinoma recurrent


subject: UNII:6XC1PAD3KF

object_name: Stage I Pancreatic Cancer AJCC v6 and v7


subject: UNII:6XC1PAD3KF

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: UNII:6XC1PAD3KF

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:6XC1PAD3KF

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: UNII:6XC1PAD3KF

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: UNII:6XC1PAD3KF

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: UNII:6XC1PAD3KF

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UNII:6XC1PAD3KF

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:231679

object_name: Advanced renal cell carcinoma


subject: CHEBI:231679

object_name: Advanced Clear Cell Renal Cell Carcinoma


subject: CHEBI:231679

object_name: Advanced Sarcomatoid Renal Cell Carcinoma


subject: CHEBI:231679

object_name: Metastatic Sarcomatoid Renal Cell Carcinoma


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: recurrent cutaneous T-cell lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: central nervous system non-hodgkin lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Marginal zone lymphoma recurrent


subject: PUBCHEM.COMPOUND:70789204

object_name: B-cell small lymphocytic lymphoma recurrent


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:70789204

object_name: B-cell adult acute lymphocytic leukemia


subject: PUBCHEM.COMPOUND:70789204

object_name: T-cell adult acute lymphocytic leukemia


subject: PUBCHEM.COMPOUND:70789204

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:85990

subject_name: Panobinostat

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: glioma


subject: UNII:GKF8S4C432

object_name: malignant glioma


subject: UNII:GKF8S4C432

object_name: brainstem cancer


subject: CHEBI:48923

subject_name: erythromycin

object_name: pulmonary fibrosis


subject: CHEBI:48923

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:48923

object_name: metabolic disease


subject: CHEBI:48923

object_name: oculocutaneous albinism


subject: CHEBI:48923

object_name: platelet storage pool deficiency


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:42355


subject: CHEBI:42355


subject: CHEBI:42355


subject: CHEBI:42355


subject: CHEBI:149504


subject: CHEBI:149504


subject: CHEBI:149504


subject: CHEBI:149504


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:63660


subject: CHEBI:63660


subject: CHEBI:63660


subject: CHEBI:63660


subject: CHEBI:63660


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:10112

subject_name: Zileuton


subject: CHEBI:10112


subject: CHEBI:10112


subject: CHEBI:10112


subject: CHEBI:10112


subject: MESH:D003069

subject_name: Coffee

object_name: type 2 diabetes mellitus


subject: MESH:D003069

object_name: Insulin resistance


subject: CHEBI:48538

subject_name: Apomorphine

object_name: Kinetic tremor


subject: PUBCHEM.COMPOUND:54605501

subject_name: Solu-Medrol

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:54605501

object_name: inflammatory bowel disease 1


subject: PUBCHEM.COMPOUND:54605501

object_name: Complication of ultrasound therapy


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: chronic obstructive pulmonary disease


subject: UNII:0T8392U5N1

subject_name: GLUCOSE OXIDASE

object_name: Upper Respiratory Infections


subject: UNII:0T8392U5N1

object_name: respiratory tract infectious disorder


subject: UNII:0T8392U5N1

object_name: Recurrent upper respiratory tract infections


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: CHEBI:17234


subject: UMLS:C0017735

subject_name: glucose oxidase


subject: UMLS:C0017735


subject: UMLS:C0017735


subject: CHEBI:232556

subject_name: Erdafitinib

object_name: Hepatic impairment


subject: UNII:0D21EQAQQA

object_name: sequelae of; stroke


subject: CHEBI:9168

subject_name: Sirolimus

object_name: nicotine dependence


subject: CHEBI:178199

subject_name: Sotorasib

object_name: cancer


subject: CHEBI:178199

object_name: neoplasm


subject: CHEBI:178199

object_name: Mutation Abnormality


subject: CHEBI:178199

object_name: Stage IV Lung Cancer AJCC v7


subject: CHEBI:178199

object_name: Non-small cell lung cancer stage III


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: endogenous depression


subject: UNII:71M78END5S

object_name: major depressive disorder


subject: CHEBI:31859

subject_name: Modafinil

object_name: Hypersomnolence


subject: CHEBI:31859

object_name: narcolepsy 1


subject: CHEBI:73611

subject_name: Met-Gly

object_name: multiple sclerosis


subject: PR:000004501

subject_name: attractin


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UNII:N4484W64JW

subject_name: LUMBROKINASE

object_name: post-treatment Lyme disease syndrome


subject: UNII:N4484W64JW

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: UNII:N4484W64JW

object_name: long COVID-19


subject: UMLS:C0247287

subject_name: lumbrokinase


subject: UMLS:C0247287


subject: UMLS:C0247287


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Multiple rib fractures


subject: CHEBI:2495

subject_name: adrenosterone

object_name: Androgen excess


subject: CHEBI:2495

object_name: type 2 diabetes mellitus


subject: CHEBI:2495

object_name: Insulin resistance


subject: CHEBI:2495

object_name: androgen; hypersecretion


subject: CHEBI:2495

object_name: endocrine system disorder


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone


subject: PUBCHEM.COMPOUND:134506


subject: PUBCHEM.COMPOUND:134506


subject: PUBCHEM.COMPOUND:134506


subject: PUBCHEM.COMPOUND:134506


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:85252

subject_name: synaptamide


subject: CHEBI:85252


subject: CHEBI:85252


subject: CHEBI:85252


subject: CHEBI:85252


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: CHEBI:89608


subject: CHEBI:89608


subject: CHEBI:89608


subject: CHEBI:89608


subject: PUBCHEM.COMPOUND:393472

subject_name: Acetogenins

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:393472

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:393472

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL1743030

subject_name: ICRUCUMAB

object_name: renal pelvis carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743030

object_name: Malignant epithelial neoplasm of renal pelvis


subject: CHEMBL.COMPOUND:CHEMBL1743030

object_name: ureter carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743030

object_name: carcinoma of urethra


subject: CHEMBL.COMPOUND:CHEMBL1743030

object_name: carcinoma of urinary tract


subject: UMLS:C2698155

subject_name: Icrucumab


subject: UMLS:C2698155


subject: UMLS:C2698155


subject: UMLS:C2698155


subject: UMLS:C2698155


subject: HMDB:HMDB0256702

subject_name: Porfimer Sodium

object_name: Recurrent Brain Neoplasm


subject: UNII:Y3834SIK5F

subject_name: PORFIMER SODIUM


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Small bowel obstruction


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:3515

subject_name: Cefuroxime

object_name: Acute appendicitis NOS (disorder)


subject: CHEBI:3515


subject: CHEBI:95341

subject_name: Baricitinib

object_name: adult dermatomyositis


subject: CHEBI:95341

object_name: dermatomyositis


subject: DRUGBANK:DB17468

subject_name: Odetiglucan

object_name: B-cell chronic lymphocytic leukemia


subject: DRUGBANK:DB17468

object_name: Chronic lymphocytic leukaemia stage 0


subject: DRUGBANK:DB17468

object_name: Chronic lymphocytic leukaemia stage 1


subject: DRUGBANK:DB17468

object_name: Chronic lymphocytic leukaemia stage 2


subject: DRUGBANK:DB17468

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:3A189DH42V

subject_name: Alemtuzumab


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: PUBCHEM.COMPOUND:46874763

object_name: Postoperative infection


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C4053628

subject_name: IONIS TTRRx

object_name: amyloidosis


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: digestive system neoplasm


subject: UNII:28X28X9OKV

object_name: Neoplasm of the gastrointestinal tract


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:70839

subject_name: Dasatinib

object_name: prostate cancer


subject: CHEBI:190514


subject: CHEBI:49375


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: UMLS:C5556424

subject_name: Lumrotatug

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UMLS:C5556424

object_name: aplastic anemia


subject: UMLS:C5556424

object_name: idiopathic aplastic anemia


subject: CHEBI:33330

subject_name: scandium atom


subject: CHEBI:33330


subject: CHEBI:33330


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000007182


subject: PR:000007182


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: PR:000050188


subject: PR:000050188


subject: UMLS:C3892043

subject_name: Ibuprofen Injection

object_name: patent ductus arteriosus


subject: CHEBI:231594

subject_name: Norgestrel

object_name: premenstrual tension


subject: CHEBI:231594

object_name: polydactyly-myopia syndrome


subject: CHEBI:231594

object_name: Menstrual disorder


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: influenza A


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Mechanical ventilation complication


subject: PUBCHEM.COMPOUND:9824461

object_name: Critical Illness


subject: PUBCHEM.COMPOUND:9824461

object_name: Adverse drug response


subject: CHEBI:84040

object_name: Insulin resistance


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: UMLS:C5557409

subject_name: Personalized Cancer Neoantigen Vaccine GAd-PEV

object_name: skin melanoma


subject: UMLS:C5557409

object_name: non-small cell lung carcinoma


subject: UMLS:C5557408

subject_name: Personalized Cancer Neoantigen Vaccine MVA-PEV


subject: UMLS:C5557408


subject: PUBCHEM.COMPOUND:18330669

subject_name: Divalproate sodium

object_name: bipolar disorder


subject: MESH:C526287

object_name: thrombotic thrombocytopenic purpura


subject: MESH:C526287

object_name: acquired thrombotic thrombocytopenic purpura


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: hormone-resistant prostate carcinoma


subject: UMLS:C5908036

subject_name: Anti-PD-1/Anti-PD-L1 Bispecific Antibody CTX-8371

object_name: melanoma


subject: UMLS:C5908036

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5908036

object_name: triple-negative breast carcinoma


subject: UMLS:C5908036

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5908036


subject: UMLS:C5908036

object_name: Hodgkin Disease


subject: UMLS:C5908036

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C5908036

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:78320

subject_name: Lactic acid

object_name: endogenous depression


subject: CHEBI:78320

object_name: major depressive disorder


subject: UMLS:C1176295

subject_name: Natrium lacticum, Homeopathic preparation


subject: UMLS:C1176295


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: Chronic small plaque psoriasis


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Allergy


subject: CHEBI:51254

object_name: History of allergies


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: Diabetic foot ulcer


subject: CHEBI:63598

subject_name: Levofloxacin


subject: UMLS:C4721940

object_name: Stage III Colon Cancer AJCC v7


subject: UMLS:C4721940

object_name: Stage III Colon Cancer AJCC v8


subject: UMLS:C4721940

object_name: Stage III Colon Cancer


subject: UMLS:C2987377

subject_name: pUMVC3-hIGFBP-2 Multi-epitope Plasmid DNA Vaccine

object_name: Stage III Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C2987377

object_name: Ovarian germ cell cancer stage IV


subject: UMLS:C2987377

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C2987377

object_name: Ovarian cancer stage III


subject: UMLS:C2987377

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2987377

object_name: Ovarian cancer stage IV


subject: CHEBI:6413

subject_name: Letrozole

object_name: Locally advanced breast cancer


subject: CHEBI:29947

subject_name: glycine residue

object_name: schizoaffective disorder


subject: CHEBI:29947

object_name: schizophrenia 18


subject: CHEBI:29947

object_name: bipolar disorder


subject: CHEBI:15428

subject_name: Glycine


subject: CHEBI:15428


subject: CHEBI:15428


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin

object_name: Traumatic Shock


subject: PUBCHEM.COMPOUND:53477739

object_name: Injury


subject: PUBCHEM.COMPOUND:53477739

object_name: urologic injuries


subject: PUBCHEM.COMPOUND:53477739

object_name: Male Genital Injuries


subject: PUBCHEM.COMPOUND:53477739

object_name: Female genital injuries


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: UMLS:C5966161


subject: UMLS:C5966161


subject: UMLS:C5966161


subject: UMLS:C5966161


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Chronic kidney disease stage 5 on dialysis


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: MESH:C557525

subject_name: SB939 compound

object_name: Solid Neoplasm


subject: MESH:C557525

object_name: hematopoietic and lymphoid system neoplasm


subject: MESH:C557525

object_name: Myelodysplasia


subject: MESH:C557525

object_name: Adult Myelodysplastic Syndrome


subject: MESH:C557525

object_name: childhood myelodysplastic syndrome


subject: MESH:C557525

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:56603532

subject_name: Pracinostat


subject: PUBCHEM.COMPOUND:56603532


subject: PUBCHEM.COMPOUND:154733034

subject_name: CpX

object_name: cystic fibrosis


subject: CHEBI:73282

subject_name: DPCPX


subject: CHEBI:36791

subject_name: Escitalopram

object_name: panic disorder


subject: CHEBI:36791

object_name: panic disorder 1


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: UMLS:C0059079

subject_name: EMLA

object_name: scrotal disorder


subject: UMLS:C0059079

object_name: Testicular Hematocele


subject: UMLS:C0059079

object_name: Hydrocele male


subject: UMLS:C0059079

object_name: spermatocele


subject: UMLS:C0059079

object_name: Spermatocele


subject: CHEBI:73610

subject_name: Met-Ala


subject: CHEBI:73610


subject: CHEBI:73610


subject: CHEBI:73610


subject: CHEBI:73610


subject: CHEBI:90325


subject: CHEBI:90325


subject: CHEBI:90325


subject: CHEBI:90325


subject: CHEBI:90325


subject: CHEBI:6810

subject_name: Metandienone


subject: CHEBI:6810


subject: CHEBI:6810


subject: CHEBI:6810


subject: CHEBI:6810


subject: CHEBI:474859

subject_name: maleic anhydride


subject: CHEBI:474859


subject: CHEBI:474859


subject: CHEBI:474859


subject: CHEBI:474859


subject: PR:000033943

subject_name: class II histocompatibility antigen, M alpha chain


subject: PR:000033943


subject: PR:000033943


subject: PR:000033943


subject: PR:000033943


subject: UniProtKB:P28078

subject_name: DMA_MOUSE Class II histocompatibility antigen, M alpha chain (sprot)


subject: UniProtKB:P28078


subject: UniProtKB:P28078


subject: UniProtKB:P28078


subject: UniProtKB:P28078


subject: UNII:618SLL9VBS

subject_name: Omiganan

object_name: acne


subject: UMLS:C4550028


subject: UMLS:C4087001


subject: UNII:45EW5LFT2J

subject_name: PEGINTERFERON ALFACON-2

object_name: chronic hepatitis B virus infection


subject: UMLS:C5238098

subject_name: Peginterferon Alfacon-2


subject: CHEBI:6801

subject_name: Metformin

object_name: Neck Carcinoma


subject: CHEBI:6801

object_name: head and neck neoplasm


subject: CHEBI:6801

object_name: oral cavity squamous cell carcinoma


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: chronic pain (diagnosis)


subject: CHEBI:5790

object_name: Chronic pain


subject: CHEBI:231683

subject_name: Anakinra

object_name: pancreatic adenocarcinoma


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: UNII:2Z03364G96

subject_name: Dapansutrile

object_name: myocardial infarction


subject: UNII:2Z03364G96

object_name: Myocardial Infarction, CTCAE


subject: UNII:2Z03364G96

object_name: Myocardial Infarction by ECG Finding


subject: PR:000005931

object_name: childhood kidney cell carcinoma


subject: UNII:I5590ES2QZ

subject_name: Fosbretabulin

object_name: choroidal neovascularization


subject: UNII:I5590ES2QZ

object_name: choroidal neovascularization (physical finding)


subject: UNII:I5590ES2QZ

object_name: degenerative myopia


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: Hypoparathyroidism following procedure


subject: PUBCHEM.COMPOUND:2091


subject: CHEBI:31186

subject_name: Alfacalcidol


subject: CHEBI:17347

subject_name: Testosterone

object_name: male infertility


subject: CHEBI:7454

subject_name: Nalbuphine

object_name: pain agnosia


subject: CHEBI:7454

object_name: Pain insensitivity


subject: CHEBI:24859

subject_name: iodine atom

object_name: Childhood Breast Carcinoma


subject: CHEBI:24859

object_name: breast carcinoma


subject: CHEBI:24859

object_name: breast cancer


subject: CHEBI:17606

subject_name: Iodine


subject: CHEBI:17606


subject: CHEBI:17606


subject: UMLS:C0885449

subject_name: Iodine, Homeopathic preparation


subject: UMLS:C0885449


subject: UMLS:C0885449


subject: UMLS:C2064827

subject_name: topical steroids

object_name: Graft Rejection


subject: GTOPDB:11763

subject_name: sotevtamab

object_name: metastatic colorectal cancer


subject: UNII:YQ3YJK67AF

subject_name: SOTEVTAMAB


subject: UMLS:C4053577

subject_name: Sotevtamab


subject: RXCUI:798361

subject_name: Havrix

object_name: hepatitis A


subject: RXCUI:798361

object_name: hepatitis B


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin

object_name: urothelial carcinoma


subject: UNII:2CN60TN6ZS

object_name: transitional cell carcinoma


subject: UNII:2CN60TN6ZS

object_name: Disseminated Malignant Neoplasm


subject: UNII:2CN60TN6ZS

object_name: Embolism, Tumor


subject: UNII:2CN60TN6ZS

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Stage IV Colorectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic Colorectal Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic malignant neoplasm to peritoneum


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C4722640

subject_name: GS/pan-Notch Inhibitor AL101

object_name: adrenal cortex carcinoma


subject: UMLS:C4722640

object_name: adenoid cystic carcinoma


subject: UMLS:C4722640

object_name: Metastatic adenoid cystic carcinoma


subject: CHEBI:91398

subject_name: Tivantinib

object_name: Mesothelioma malignant recurrent


subject: CHEBI:91398

object_name: malignant epithelioid mesothelioma


subject: CHEBI:91398

object_name: sarcomatoid mesothelioma


subject: CHEBI:91398

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v7


subject: CHEBI:91398

object_name: Stage III Pleural Malignant Mesothelioma AJCC v7


subject: PUBCHEM.COMPOUND:60139

subject_name: (D-Ala1)-Peptide T

object_name: peripheral nervous system disorder


subject: UNII:05DYM3ZS1X

subject_name: Peptide T


subject: UMLS:C0030953

subject_name: peptide-T


subject: UNII:2O4BE0K238

subject_name: Volanesorsen

object_name: lipodystrophy


subject: UMLS:C3896730

object_name: female reproductive organ cancer


subject: CHEBI:40799

subject_name: Boldione

object_name: Metastatic Castration-Sensitive Prostate Carcinoma


subject: UMLS:C0768182

subject_name: Bexxar

object_name: follicular lymphoma


subject: CHEBI:18067

subject_name: Phylloquinone

object_name: Intracerebral hemorrhage in cerebellum


subject: UMLS:C2932763

object_name: Alzheimer disease


subject: CHEBI:64073

object_name: Metabolic stress hyperglycemia


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: CHEBI:6801

subject_name: Metformin

object_name: Diastolic dysfunction


subject: UMLS:C5557527

subject_name: RNA-LPX BNT112

object_name: prostate carcinoma


subject: UMLS:C5557527

object_name: prostate cancer


subject: PR:000010754

subject_name: mitochondrial tumor suppressor 1

object_name: Pancreatic Cystic Lesion


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: infectious disease


subject: CHEBI:8768

subject_name: Rabeprazole


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: adult T-cell leukemia/lymphoma


subject: UNII:7XL5ISS668

object_name: lymphoid system disorder


subject: UNII:7XL5ISS668

object_name: Lymphadenopathy


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:60791

subject_name: Xylocard

object_name: Wound Complication


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:8228

object_name: acute myeloid leukemia


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Refractory Neuroblastoma


subject: CHEBI:201431

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: CHEBI:201431

object_name: Recurrent Rhabdomyosarcoma


subject: CHEBI:201431

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:201431

object_name: Neuroblastoma recurrent


subject: CHEBI:201431

object_name: Refractory Rhabdomyosarcoma


subject: CHEBI:201431

object_name: Refractory Desmoplastic Small Round Cell Tumor


subject: CHEBI:201431

object_name: Recurrent Desmoplastic Small Round Cell Tumor


subject: CHEBI:201431

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:201431

object_name: Refractory Malignant Peripheral Nerve Sheath Tumor


subject: CHEBI:201431

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: CHEBI:201431

object_name: desmoplastic small round cell tumor


subject: CHEBI:201431

object_name: Adult Desmoplastic Small Round Cell Tumor


subject: CHEBI:201431

object_name: Recurrent Malignant Peripheral Nerve Sheath Tumor


subject: CHEBI:201431

object_name: Ewing sarcoma/peripheral primitive neuroectodermal tumor


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:2948

subject_name: Azathioprine

object_name: gout


subject: CHEBI:60802

subject_name: ropivacaine

object_name: outcomes general quality of life


subject: CHEBI:60802

object_name: Perceived quality of life


subject: CHEBI:60802

object_name: Good quality of life


subject: UMLS:C0667595

object_name: inflammatory bowel disease 1


subject: CHEBI:230391

subject_name: Tetomilast


subject: CHEBI:230391

object_name: Crohn disease


subject: CHEBI:5523

subject_name: Goserelin

object_name: Radiation Sickness


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: Left Ventricular Diastolic Dysfunction, CTCAE


subject: UniProtKB:P19726

object_name: Left ventricular diastolic dysfunction


subject: UniProtKB:P19726

object_name: hyperlipidemia


subject: UNII:A17W0640NB

object_name: mild neurocognitive disorder


subject: UNII:A17W0640NB

object_name: mild cognitive impairment


subject: UNII:A17W0640NB

object_name: amnesia


subject: UNII:A17W0640NB

object_name: Memory Impairment, CTCAE 5.0


subject: UNII:A17W0640NB

object_name: Alzheimer disease type 1


subject: UNII:A17W0640NB

object_name: Alzheimer disease


subject: CHEBI:18248

subject_name: Iron

object_name: Abnormal delivery


subject: CHEBI:64816

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:126480263

subject_name: NEROFE

object_name: Myelodysplasia


subject: UNII:SR717JCM7M


subject: UMLS:C2974969

subject_name: Nerofe


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Branch retinal vein occlusion with macular edema


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: lupus nephritis


subject: CHEBI:201431

object_name: EXCESS LMW-DNA


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:16118

subject_name: Berberine


subject: CHEBI:16118

object_name: hyperlipoproteinemia


subject: CHEBI:16118

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:16118

object_name: Serum lipids high (finding)


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Malignant neoplasm of female genital organs


subject: UNII:JD5ZWE631K

object_name: Hepatic impairment


subject: CHEBI:31627

subject_name: FP 83

object_name: Post-Operative Pain


subject: CHEBI:4055

subject_name: Cytisine

object_name: coronary artery disorder


subject: CHEBI:4055

object_name: coronary atherosclerosis


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Depressed mood


subject: CHEBI:85078

object_name: Cancer patients and suicide and depression


subject: CHEBI:85078

object_name: Depressed - symptom


subject: CHEBI:85078

object_name: Depression, CTCAE


subject: UMLS:C1522480

subject_name: AMG 951

object_name: non-small cell lung carcinoma


subject: GTOPDB:5065

subject_name: TRAIL


subject: PR:000002106

subject_name: tumor necrosis factor ligand superfamily member 10


subject: CHEBI:44915

subject_name: Propofol

object_name: abnormal respiratory airway resistance


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: severe combined immunodeficiency


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C0004149

subject_name: ATGAM

object_name: Bone marrow depression


subject: UMLS:C0004149

object_name: pancytopenia


subject: UMLS:C0004149

object_name: Bone marrow hypocellularity


subject: UMLS:C0004149


subject: UMLS:C0004149

object_name: osteopetrosis


subject: UMLS:C0004149

object_name: Fanconi anemia


subject: UMLS:C0004149

object_name: Fanconi anemia complementation group A


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: PUBCHEM.COMPOUND:3086007

subject_name: Ginsenosides

object_name: abdominal obesity-metabolic syndrome


subject: PUBCHEM.COMPOUND:3086007

object_name: metabolic syndrome X


subject: CHEBI:74978

subject_name: ginsenoside


subject: CHEBI:74978


subject: PUBCHEM.COMPOUND:53236401

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:53236401

object_name: major depressive disorder


subject: UNII:3HP012Q0FH

object_name: histoplasmosis retinitis


subject: UNII:3HP012Q0FH

object_name: choroidal neovascularization


subject: UNII:3HP012Q0FH

object_name: choroidal neovascularization (physical finding)


subject: UNII:2H1PA8H1EN

subject_name: Pegaptanib


subject: UNII:2H1PA8H1EN


subject: UNII:2H1PA8H1EN


subject: UMLS:C5222496

subject_name: Repository Corticotropin Injection


subject: UMLS:C5222496

object_name: proteinuria


subject: UMLS:C5222496

object_name: Proteinuria of undiagnosed cause


subject: UMLS:C5222496

object_name: Proteinuria, CTCAE 3.0


subject: UMLS:C5222496

object_name: Proteinuria, CTCAE 5.0


subject: UNII:N658GY6L3E

subject_name: Tebentafusp

object_name: skin melanoma


subject: UMLS:C2986393


subject: CHEBI:6801

subject_name: Metformin

object_name: vitamin D deficiency


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Depressed mood


subject: CHEBI:89324

object_name: Cancer patients and suicide and depression


subject: CHEBI:89324

object_name: Depressed - symptom


subject: CHEBI:89324

object_name: Depression, CTCAE


subject: CHEBI:89324

object_name: Insulin resistance


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: asthma


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: psoriasis


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:231614

subject_name: Nivolumab

object_name: penile neoplasm


subject: UMLS:C2346820


subject: UNII:6Y83I5F10I

subject_name: INSULIN PEGLISPRO

object_name: type 1 diabetes mellitus 1


subject: UNII:6Y83I5F10I

object_name: type 1 diabetes mellitus


subject: UMLS:C4550895

subject_name: Insulin peglispro


subject: UMLS:C4550895


subject: UNII:U59UGK3IPC

subject_name: Ublituximab

object_name: Autoimmunity


subject: UMLS:C2934225


subject: MESH:C079198

subject_name: S 1 (combination)


subject: CHEBI:7772

subject_name: omeprazole

object_name: active peptic ulcer disease


subject: CHEBI:7772

object_name: Gastrointestinal hemorrhage


subject: CHEBI:77260


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: Liver Fibrosis


subject: CHEBI:32016

object_name: Chronic liver disease


subject: UMLS:C5667024

object_name: biliary tract cancer


subject: UMLS:C5667024

object_name: liver carcinoma


subject: CHEBI:8988

object_name: colon cancer liver metastasis


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:15552

subject_name: Epoprostenol

object_name: Surgical procedure finding


subject: UMLS:C2825061

subject_name: Prostacycline [EPC]


subject: UMLS:C4727698

subject_name: Miptenalimab

object_name: non-small cell lung carcinoma


subject: CHEBI:229764

subject_name: Selinexor

object_name: Childhood Breast Carcinoma


subject: CHEBI:229764

object_name: breast carcinoma


subject: CHEBI:229764

object_name: breast cancer


subject: UNII:0C1JUU9S0L

object_name: Small cell lung cancer extensive stage


subject: UMLS:C1831857

subject_name: MGMTP140K-encoding retroviral vector

object_name: glioblastoma


subject: UMLS:C1831857

object_name: Brain Stem Glioblastoma


subject: UMLS:C1831857

object_name: glioma susceptibility 1


subject: CHEBI:132922

object_name: Symptomatic irreversible pulpitis


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: UNII:NL053ABE4J

subject_name: SERRAPEPTASE


subject: PUBCHEM.COMPOUND:171666295

subject_name: serralysin


subject: UMLS:C0074389

subject_name: Serrapeptase


subject: UNII:35A26E427H

subject_name: Reslizumab

object_name: pulmonary eosinophilia


subject: UNII:35A26E427H

object_name: Asthmatic pulmonary eosinophilia


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: traumatic encephalopathy


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: PUBCHEM.COMPOUND:66550324

subject_name: Miricorilant


subject: UNII:311Y5GV21M


subject: CHEBI:6402

subject_name: Leflunomide

object_name: siderosis


subject: CHEBI:74947

subject_name: Thalidomide

object_name: arachnoiditis


subject: CHEBI:74947

object_name: Arachnoiditis, CTCAE


subject: CHEBI:49005

subject_name: Deferasirox

object_name: Transfusion dependent thalassaemia beta


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: metastatic neoplasm


subject: CHEBI:41774

object_name: Embolism, Tumor


subject: CHEBI:41774

object_name: Neoplasm Metastasis


subject: CHEBI:41774

object_name: Metastatic Lesion


subject: UMLS:C2984503

subject_name: Urokinase-Derived Peptide A6

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C2984503

object_name: chronic leukemia


subject: UMLS:C2917382

subject_name: Erythropoiesis-stimulating Agent [EPC]

object_name: Anemia in chronic kidney disease


subject: CHEBI:35677

subject_name: Betahistine

object_name: Recurrent major depressive disorder with atypical features


subject: CHEBI:7025

subject_name: Mupirocin

object_name: reported history of cataract surgery


subject: CHEBI:7025

object_name: endophthalmitis


subject: CHEBI:7025

object_name: Endophthalmitis, CTCAE


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Migraine with or without aura


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: coronary artery disorder


subject: CHEBI:28911

object_name: coronary atherosclerosis


subject: CHEBI:28911

object_name: myocardial infarction


subject: CHEBI:28911

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:28911

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:28911

object_name: stroke disorder


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UNII:P6YC3EG204

subject_name: Erythrotin


subject: UNII:P6YC3EG204


subject: UNII:P6YC3EG204


subject: UNII:P6YC3EG204


subject: UNII:P6YC3EG204


subject: UNII:P6YC3EG204


subject: CHEBI:15982

subject_name: cob(I)alamin


subject: CHEBI:15982


subject: CHEBI:15982


subject: CHEBI:15982


subject: CHEBI:15982


subject: CHEBI:15982


subject: UMLS:C3714801

subject_name: Cyanocobalamin Drug Class


subject: UMLS:C3714801


subject: UMLS:C3714801


subject: UMLS:C3714801


subject: UMLS:C3714801


subject: UMLS:C3714801


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:27306


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class


subject: UMLS:C3714638


subject: UMLS:C3714638


subject: UMLS:C3714638


subject: UMLS:C3714638


subject: UMLS:C3714638


subject: UMLS:C4086734

object_name: Myelodysplasia


subject: UMLS:C4086734

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C4086734

object_name: childhood myelodysplastic syndrome


subject: UMLS:C4086734

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C4086734

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4086734

object_name: acute myeloid leukemia


subject: UMLS:C5565354

object_name: hepatitis C


subject: UMLS:C0873127

subject_name: Burdock preparation

object_name: hypertension


subject: UMLS:C0873127

object_name: Hypertension, CTCAE


subject: UMLS:C5203356

subject_name: Tocilizumab Liquid Injection

object_name: Myasthenia Gravis, Generalized


subject: UMLS:C2959259

subject_name: Injection, tocilizumab, 1 mg administered


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: CHEBI:50867

subject_name: Ciprofibrate

object_name: Diastolic dysfunction


subject: CHEBI:59905


subject: CHEBI:59905

object_name: cerebrovascular disorder


subject: CHEBI:59905

object_name: Stroke (heart beat)


subject: CHEBI:59905

object_name: Stroke, CTCAE


subject: CHEBI:18243

subject_name: Dopamine


subject: CHEBI:18243


subject: CHEBI:18243


subject: CHEBI:18243


subject: UNII:YI437801BE

subject_name: Mogamulizumab

object_name: Pre T-ALL


subject: UNII:YI437801BE

object_name: T-cell leukemia


subject: UNII:YI437801BE

object_name: adult lymphoma


subject: UNII:YI437801BE

object_name: lymphoma


subject: UNII:YI437801BE

object_name: pediatric lymphoma


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: CHEBI:8382

subject_name: Prednisone

object_name: Carcinoma breast stage IV


subject: CHEBI:57858

subject_name: atropinium

object_name: Cerebral hypoperfusion


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: CHEBI:44915

subject_name: Propofol


subject: PUBCHEM.COMPOUND:541197

subject_name: Norethindrone acetate

object_name: Abnormal uterine bleeding


subject: CHEBI:7627

subject_name: Norethisterone


subject: UNII:AQK7UBA1LS

subject_name: Luspatercept

object_name: Clonal Cytopenia of Undetermined Significance


subject: UNII:AQK7UBA1LS

object_name: thrombocytopenia


subject: UNII:AQK7UBA1LS

object_name: leukopenia


subject: UNII:AQK7UBA1LS

object_name: neutropenia


subject: UMLS:C3641690


subject: UMLS:C3641690


subject: UMLS:C3641690


subject: UMLS:C3641690


subject: UMLS:C0021658

subject_name: Humulin N

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0021658

object_name: obesity


subject: UMLS:C0021658

object_name: Obesity, CTCAE


subject: DRUGBANK:DB18532

subject_name: Lactobacillus brevis

object_name: mucositis


subject: UMLS:C2001299

object_name: atrial fibrillation


subject: UMLS:C2001299

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C2001299

object_name: Atrial Fibrillation, CTCAE


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Malignant neoplasm of stomach stage IV


subject: GTOPDB:9758

object_name: Locally Advanced Gastric Adenocarcinoma


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: PUBCHEM.COMPOUND:3298

subject_name: Eicosapentaenoic acid ethyl ester

object_name: Acute Heart Failure Related to COVID-19


subject: PUBCHEM.COMPOUND:3298

object_name: Acute heart failure


subject: PUBCHEM.COMPOUND:3298

object_name: acute myocardial infarction


subject: PUBCHEM.COMPOUND:3298

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C0207789

subject_name: Epadel


subject: UMLS:C0207789


subject: UMLS:C0207789


subject: UMLS:C0207789


subject: CHEBI:84883

subject_name: Icosapent ethyl


subject: CHEBI:84883


subject: CHEBI:84883


subject: CHEBI:84883


subject: CHEBI:28364

subject_name: Icosapent


subject: CHEBI:28364


subject: CHEBI:28364


subject: CHEBI:28364


subject: CHEBI:7454

subject_name: Nalbuphine

object_name: Surgical procedure finding


subject: CHEBI:7454

object_name: post operative nausea and vomiting


subject: UMLS:C5417905

subject_name: Anti-CTLA-4/Anti-PD-1 Monoclonal Antibody Combination BCD-217

object_name: melanoma


subject: UMLS:C5417905

object_name: metastatic melanoma


subject: UNII:8L7891MRB6

subject_name: Encorafenib

object_name: colorectal neoplasm


subject: UNII:8L7891MRB6

object_name: colon carcinoma


subject: UNII:8L7891MRB6

object_name: colon cancer


subject: UNII:8L7891MRB6

object_name: colorectal adenocarcinoma


subject: UNII:8L7891MRB6

object_name: Colon Neoplasm


subject: UNII:8L7891MRB6

object_name: benign colon neoplasm


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: CHEBI:135544

subject_name: Ilaprazole

object_name: Peptic Ulcer Hemorrhage


subject: CHEBI:28747

subject_name: Picolinic acid


subject: CHEBI:53407

subject_name: poly(lactic acid) macromolecule


subject: CHEBI:60159

subject_name: poly(lactic acid) polymer


subject: CHEBI:180653

subject_name: Molnupiravir

object_name: kidney failure


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: nasopharyngeal carcinoma


subject: MESH:C520255

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: MESH:C520255

object_name: malignant tumor of nasopharynx


subject: UMLS:C2934122

object_name: ovarian carcinoma


subject: UMLS:C2934122

object_name: malignant epithelial tumor of ovary


subject: CHEBI:5494

subject_name: ritropirronium bromide

object_name: acute cholecystitis


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: CHEBI:5384

subject_name: Glipizide

object_name: type 2 diabetes mellitus


subject: MESH:C055753

subject_name: Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate

object_name: diphtheria


subject: MESH:C055753

object_name: pertussis


subject: MESH:C055753

object_name: tetanus


subject: MESH:C055753

object_name: poliomyelitis


subject: DRUGBANK:DB10629

subject_name: Blueberry

object_name: obesity due to melanocortin 4 receptor deficiency


subject: DRUGBANK:DB10629

object_name: obesity


subject: DRUGBANK:DB10629

object_name: Obesity, CTCAE


subject: DRUGBANK:DB10629

object_name: gestational diabetes


subject: DRUGBANK:DB10629

object_name: high-risk pregnancy


subject: MESH:C000721609

subject_name: blueberry extract


subject: MESH:C000721609


subject: MESH:C000721609


subject: MESH:C000721609


subject: MESH:C000721609


subject: UNII:SE2KH7T06F

object_name: malignant neoplasm of breast stage IV


subject: UMLS:C4287766

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C4287766


subject: CHEBI:7640

subject_name: Nortriptyline

object_name: small cell carcinoma


subject: CHEBI:7640

object_name: small cell lung carcinoma


subject: UNII:H18SKU3289

subject_name: visilizumab

object_name: adult lymphoma


subject: UNII:H18SKU3289

object_name: lymphoma


subject: UNII:H18SKU3289

object_name: pediatric lymphoma


subject: UNII:H18SKU3289

object_name: small intestine cancer


subject: UNII:H18SKU3289

object_name: small intestine carcinoma


subject: UMLS:C1135148

subject_name: Nuvion


subject: UMLS:C1135148


subject: UMLS:C1135148


subject: UMLS:C1135148


subject: UMLS:C1135148


subject: UMLS:C4082808

subject_name: Advagraf

object_name: Adherence To Medication Regime


subject: UMLS:C5206707

subject_name: Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: chronic liver failure


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate

object_name: hepatitis C


subject: CHEBI:167450


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:8081

subject_name: Phentolamine

object_name: presbyopia


subject: CHEBI:35457

subject_name: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor

object_name: mitral valve insufficiency


subject: CHEBI:35457

object_name: heart failure


subject: CHEBI:35457

object_name: Heart Failure, CTCAE


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist


subject: UMLS:C0521942


subject: UMLS:C0521942


subject: UMLS:C3536793

subject_name: Angiotensin 2 Receptor Blocker [EPC]


subject: UMLS:C3536793


subject: UMLS:C3536793


subject: UMLS:C5783940


subject: UMLS:C5783940


subject: UMLS:C5783940


subject: CHEBI:62466

subject_name: Prolycopene

object_name: healthy, no evidence of disease


subject: CHEBI:15948

subject_name: Lycopene


subject: UNII:N3KQ8A1E0X

object_name: Crohn disease


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: contracture


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Joint contracture


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: x-ray of toe: deformity contracture


subject: UNII:OPL214POJ1

subject_name: Adipiplon

object_name: Primary Insomnia


subject: UMLS:C1644791

subject_name: Ambien CR


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: type 1 diabetes mellitus


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C5557475

object_name: plasma cell myeloma


subject: UMLS:C5417834


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: neuromyelitis optica


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: complete trisomy 21


subject: CHEBI:127342

object_name: Down syndrome


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL


subject: PUBCHEM.COMPOUND:86217377


subject: CHEBI:144551

subject_name: Oxybutynin


subject: CHEBI:144551


subject: UMLS:C5700426

subject_name: furmonertinib

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C2985197

object_name: diffuse large B-cell lymphoma


subject: UMLS:C2985197

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C2985197

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:75HI05N8HS

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5237451

subject_name: Menin-MLL Inhibitor SNDX-5613


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Local anaesthetic systemic toxicity


subject: CHEBI:47426

subject_name: Furosemide

object_name: Chronic kidney disease requiring chronic dialysis


subject: UMLS:C0354100

subject_name: Loop Diuretics


subject: UMLS:C3536704

subject_name: Loop Diuretic [EPC]


subject: MESH:D013607

subject_name: Tablets


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: Untreated Chronic Lymphocytic Leukemia


subject: CHEBI:50459

object_name: Disorder of fluid AND/OR electrolyte


subject: CHEBI:50459

object_name: coagulation; intravascular


subject: GTOPDB:9704

subject_name: isunakinra

object_name: metastatic colorectal cancer


subject: UNII:5QM1ZK6VXZ

subject_name: ISUNAKINRA


subject: UMLS:C4519727

subject_name: Isunakinra


subject: CHEBI:73826

subject_name: Asp-Ala

object_name: chronic kidney disease


subject: CHEBI:73826

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:17256

subject_name: DEOXYADENOSINE


subject: CHEBI:17256


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:63605

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:63605

object_name: metastatic melanoma


subject: CHEBI:63605

object_name: Melanoma recurrent


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: Childhood Synovial Sarcoma


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Synovial Sarcoma


subject: PUBCHEM.COMPOUND:3368

object_name: synovial sarcoma


subject: PUBCHEM.COMPOUND:3368

object_name: myxoid liposarcoma


subject: PUBCHEM.COMPOUND:3368

object_name: myxoid/round cell liposarcoma


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:60799

subject_name: Esketamine

object_name: septic shock


subject: CHEBI:60799

object_name: Mechanical ventilation complication


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: neurotic excoriation


subject: CHEBI:6367

object_name: Skin-picking


subject: GTOPDB:13334

subject_name: bezlotoxumab

object_name: Clostridium infectious disease


subject: UNII:4H5YMK1H2E

subject_name: Bezlotoxumab


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: diabetic kidney disease


subject: CHEBI:6503

object_name: type 1 diabetes mellitus


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: CHEBI:157844

subject_name: Glu-Arg

object_name: Diabetic peripheral neuropathy


subject: CHEBI:33379

subject_name: erbium


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: PR:000007204

subject_name: estrogen receptor


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: congenital heart block


subject: CHEBI:5801

object_name: neonatal lupus erythematosus


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: inborn mitochondrial metabolism disorder


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: Infection of bloodstream


subject: CHEBI:6770


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: UMLS:C1314417


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:43968


subject: CHEBI:151315

subject_name: Heparin

object_name: ST-elevation myocardial infarction


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Resectable Mass


subject: UNII:28X28X9OKV

object_name: Metastatic carcinoma to liver


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: Adult Acute Lymphoblastic Leukemia in Complete Remission


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:11306691

object_name: Chronic uremia


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: chronic pain (diagnosis)


subject: CHEBI:73604

object_name: Chronic pain


subject: MESH:D010919

subject_name: Placebos


subject: MESH:D010919


subject: MESH:D010919

object_name: transient myeloproliferative syndrome


subject: MESH:D010919

object_name: tibial muscular dystrophy


subject: MESH:D010919

object_name: temporomandibular joint dysfunction syndrome


subject: MESH:D010919

object_name: temporomandibular joint disorder


subject: MESH:D010919

object_name: Pain of temporomandibular joint


subject: MESH:D010919

object_name: bruxism


subject: MESH:D010919

object_name: sleep disorder


subject: CHEBI:9654

subject_name: Trazodone


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:151315

object_name: acute coronary syndrome


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O


subject: CHEBI:35430

subject_name: DIIODOTHYRONINE

object_name: Presenile dementia


subject: CHEBI:35430

object_name: dementia


subject: CHEBI:35430

object_name: Agitation, CTCAE 3.0


subject: CHEBI:35430

object_name: Agitation


subject: CHEBI:35430

object_name: Agitation, CTCAE 5.0


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:29298

subject_name: ditritium


subject: CHEBI:29298


subject: CHEBI:29298


subject: CHEBI:29298


subject: CHEBI:29298


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: UniProtKB:Q06666

subject_name: T2_MOUSE Octapeptide-repeat protein T2 (sprot)


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: PR:000034234

subject_name: octapeptide-repeat protein T2


subject: PR:000034234


subject: PR:000034234


subject: PR:000034234


subject: PR:000034234


subject: CHEBI:172127


subject: CHEBI:172127


subject: CHEBI:172127


subject: CHEBI:172127


subject: CHEBI:172127


subject: CHEBI:30813

subject_name: Capric acid


subject: CHEBI:30813


subject: CHEBI:30813


subject: CHEBI:30813


subject: CHEBI:30813


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Telangiectasia of macula lutea


subject: UNII:ZL1R02VT79

object_name: Macular telangiectasia


subject: UMLS:C1170437

subject_name: Normal Saline Flush

object_name: uterine disease


subject: CHEBI:47657

subject_name: Roflumilast

object_name: Androgen excess


subject: CHEBI:38940

subject_name: Sunitinib

object_name: pancreatic endocrine carcinoma


subject: UMLS:C4733036

subject_name: Medihoney

object_name: radiodermatitis


subject: UMLS:C4733036

object_name: Childhood Breast Carcinoma


subject: UMLS:C4733036

object_name: breast carcinoma


subject: UMLS:C4733036

object_name: breast cancer


subject: UNII:7SQY4ZUD30

subject_name: Dinutuximab

object_name: nodular ganglioneuroblastoma


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:6067

subject_name: Isotretinoin


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: UMLS:C5856111

subject_name: HBV mRNA Vaccine

object_name: liver carcinoma


subject: CHEBI:7459

subject_name: Naloxone

object_name: pruritus chronic


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: blood protein disease


subject: UNII:4Z63YK6E0E

object_name: plasma cell neoplasm


subject: UNII:4Z63YK6E0E

object_name: corneal disease


subject: UNII:4Z63YK6E0E

object_name: neoplasm


subject: CHEBI:4511

subject_name: Dicloxacillin

object_name: atopic eczema


subject: CHEBI:4511

object_name: Atopic dermatitis flare


subject: CHEBI:4511

object_name: atopic eczema/dermatitis (non-specific)


subject: UMLS:C4085974

object_name: colon carcinoma


subject: CHEBI:134736

subject_name: Vintafolide

object_name: Advanced cancer


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: thalassemia


subject: CHEBI:35176

object_name: splenectomy; status


subject: CHEBI:35176

object_name: Immunosuppression


subject: CHEBI:35176

object_name: Decreased Immunologic Activity [PE]


subject: CHEMBL.COMPOUND:CHEMBL5314976

object_name: Hypercholesterolemia


subject: CHEMBL.COMPOUND:CHEMBL5314976

object_name: familial hypercholesterolemia


subject: DRUGBANK:DB19284

subject_name: Pseudomonas aeruginosa

object_name: bladder tumor


subject: DRUGBANK:DB19284

object_name: urinary bladder carcinoma


subject: DRUGBANK:DB19284

object_name: urinary bladder cancer


subject: DRUGBANK:DB19284

object_name: childhood bladder carcinoma


subject: CHEBI:229764

subject_name: Selinexor

object_name: squamous cell carcinoma


subject: UMLS:C3640806


subject: UMLS:C5448108

subject_name: Alda 341

object_name: parotid gland neoplasm


subject: UMLS:C5448108

object_name: submandibular gland neoplasm


subject: CHEBI:27306

subject_name: vitamin B6

object_name: endometrial cancer


subject: CHEBI:27306

object_name: uterine corpus cancer


subject: CHEBI:27306

object_name: endometrial carcinoma


subject: CHEBI:27306

object_name: fallopian tube carcinoma


subject: CHEBI:27306

object_name: fallopian tube cancer


subject: CHEBI:27306

object_name: ovarian cancer


subject: CHEBI:27306

object_name: ovarian neoplasm


subject: CHEBI:27306

object_name: ovarian carcinoma


subject: CHEBI:27306

object_name: peritoneum cancer


subject: CHEBI:27306

object_name: Drug toxicity


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: gestational diabetes


subject: HMDB:HMDB0001349

object_name: pregnancy related


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: MESH:D013607

subject_name: Tablets

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: uveal melanoma


subject: CHEBI:41879

object_name: Disorder of retina caused by radiation


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: Encounter due to In vitro fertilization


subject: PUBCHEM.COMPOUND:4568

subject_name: Nystatin A1

object_name: digestive system disorder


subject: PUBCHEM.COMPOUND:4568

object_name: stomatitis


subject: CHEMBL.COMPOUND:CHEMBL5465559

subject_name: NYSTATIN


subject: CHEMBL.COMPOUND:CHEMBL5465559


subject: CHEBI:7660

subject_name: nystatin


subject: CHEBI:7660


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: uterine sarcoma


subject: CHEBI:6801

subject_name: Metformin

object_name: liver neoplasm


subject: CHEBI:6801

object_name: Adult Liver Carcinoma


subject: CHEBI:6801

object_name: renal carcinoma


subject: CHEBI:6801

object_name: kidney neoplasm


subject: CHEBI:6801

object_name: kidney cancer


subject: CHEBI:6801

object_name: skin melanoma


subject: CHEBI:76978

subject_name: Tricaprylin

object_name: primary progressive multiple sclerosis


subject: CHEBI:76978

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:4953

subject_name: Exemestane

object_name: malignant neoplasm of breast stage I


subject: CHEBI:4953

object_name: breast carcinoma in situ


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: stroke disorder


subject: CHEBI:6888

object_name: cerebrovascular disorder


subject: CHEBI:6888

object_name: Stroke (heart beat)


subject: CHEBI:6888

object_name: Stroke, CTCAE


subject: UNII:7SI2UZG934

subject_name: Condoliase

object_name: lumbar disk disease


subject: UNII:7SI2UZG934

object_name: lumbar disk degenerative disorder


subject: UNII:7SI2UZG934

object_name: intervertebral disk degenerative disorder


subject: CHEBI:80230

object_name: Colorectal cancer stage III


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Mantle cell lymphoma recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: anaplastic large cell lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Adult Burkitt Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: GTOPDB:13613

subject_name: lumasiran

object_name: cardiovascular disorder


subject: GTOPDB:13613

object_name: Heart Disease Risk Factors


subject: GTOPDB:13613

object_name: Hyperoxalaemia


subject: GTOPDB:13613

object_name: Chronic kidney disease requiring chronic dialysis


subject: UNII:RZT8C352O1

subject_name: Lumasiran


subject: UNII:RZT8C352O1


subject: UNII:RZT8C352O1


subject: UNII:RZT8C352O1


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UNII:3H8GSZ4SQL

subject_name: Avatrombopag

object_name: Severe Aplastic Anemia


subject: UNII:3H8GSZ4SQL

object_name: severe aplastic anemia


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: sarcopenia


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: CHEBI:45924

subject_name: Trimethoprim

object_name: pituitary gland adenoma


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEMBL.COMPOUND:CHEMBL2109217

subject_name: PERFLUTREN PROTEIN-TYPE A MICROSPHERES

object_name: intrahepatic cholangiocarcinoma


subject: UMLS:C1509955

subject_name: Perflutren Protein-A Microsphere


subject: CHEBI:145365

subject_name: Crenolanib


subject: UNII:DEH7Q6472O

subject_name: Ladarixin

object_name: type 1 diabetes mellitus 1


subject: MESH:C000613429

subject_name: FluMist

object_name: cancer


subject: MESH:C000613429

object_name: neoplasm


subject: UMLS:C0757679

object_name: Vomiting, CTCAE


subject: UMLS:C0757679

object_name: Vomiting


subject: UMLS:C0757679

object_name: Nausea, CTCAE_5


subject: UMLS:C0757679

object_name: Nausea


subject: UMLS:C0757679

object_name: Nausea, CTCAE_3


subject: UNII:J9U8H9VQV0

object_name: tuberculosis


subject: UMLS:C2987409

object_name: Chronic lymphocytic leukaemia refractory


subject: UMLS:C2987409

object_name: prolymphocytic leukemia


subject: UMLS:C2987409

object_name: Chronic lymphocytic leukaemia stage 1


subject: UMLS:C2987409

object_name: B-cell small lymphocytic lymphoma stage I


subject: UMLS:C2987409

object_name: Chronic lymphocytic leukaemia stage 2


subject: UMLS:C2987409

object_name: Chronic lymphocytic leukaemia stage 4


subject: UMLS:C2987409

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UMLS:C2987409

object_name: Chronic lymphocytic leukaemia stage 3


subject: UMLS:C2987409

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C2987409

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:78030

object_name: triple-negative breast carcinoma


subject: CHEBI:78030

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:78030

object_name: head and neck squamous cell carcinoma


subject: CHEBI:78030

object_name: esophageal squamous cell carcinoma


subject: CHEBI:78030

object_name: cervical squamous cell carcinoma


subject: CHEBI:78030

object_name: squamous cell lung carcinoma


subject: CHEBI:78030

object_name: pancreatic neoplasm


subject: CHEBI:78030

object_name: exocrine pancreatic carcinoma


subject: CHEBI:78030

object_name: malignant pancreatic neoplasm


subject: CHEBI:78030

object_name: melanoma


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C1314420

subject_name: INJECTION, RASBURICASE, 0.5 MG ADMINISTERED

object_name: Chronic gouty arthritis


subject: UMLS:C1314420

object_name: gout


subject: UNII:08GY9K1EUO

subject_name: Rasburicase


subject: UNII:08GY9K1EUO


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: CHEBI:75722

subject_name: Tramadol

object_name: Shoulder pain


subject: UNII:5M691HL4BO

subject_name: glatiramer acetate

object_name: Multiple sclerosis relapse


subject: CHEBI:3757

subject_name: Clonidine

object_name: pervasive developmental disorder


subject: CHEBI:3757

object_name: autism


subject: CHEBI:3757

object_name: autism spectrum disorder


subject: CHEBI:74947

subject_name: Thalidomide

object_name: inherited hemoglobinopathy


subject: CHEBI:74947

object_name: hemoglobinopathy


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: fetal hemoglobin measurement


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: Nausea gravidarum


subject: CHEBI:6950

object_name: Vomiting of pregnancy


subject: CHEBI:7773

subject_name: Ondansetron

object_name: hyperemesis gravidarum


subject: CHEBI:7773


subject: CHEBI:3745

subject_name: clindamycin

object_name: hip infection


subject: CHEBI:3745

object_name: infection; knee, joint


subject: UMLS:C1512511

subject_name: Human Papilloma Virus Vaccine

object_name: Persistent Infection


subject: UMLS:C1512511

object_name: Vaginal intraepithelial neoplasia


subject: UMLS:C1512511

object_name: vulvar intraepithelial neoplasia


subject: UMLS:C0540212

object_name: type 2 diabetes mellitus


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: Acute miliary tuberculosis


subject: UNII:6GNT3Y5LMF

object_name: miliary tuberculosis


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: PUBCHEM.COMPOUND:135512673


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: PALB2 Gene Mutation


subject: UMLS:C5774009

object_name: transient ischemic attack


subject: UMLS:C5774009

object_name: Acute Ischemic Stroke


subject: UMLS:C5774009

object_name: Ischemic stroke


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: Pregnant


subject: UMLS:C0021735

subject_name: Viraferon

object_name: cancer


subject: UMLS:C0021735

object_name: neoplasm


subject: PUBCHEM.COMPOUND:16683012

subject_name: Sodium stibogluconate


subject: PUBCHEM.COMPOUND:16683012


subject: PUBCHEM.COMPOUND:16683013

subject_name: Stibogluconate


subject: PUBCHEM.COMPOUND:16683013


subject: CHEBI:28148


subject: CHEBI:28148


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: congestive heart failure


subject: CHEBI:6427

subject_name: Leuprolide

object_name: myeloproliferative neoplasm


subject: CHEBI:6427

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:6427

object_name: acute myeloid leukemia


subject: CHEBI:6427

object_name: plasma cell myeloma


subject: CHEBI:6427

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:6427

object_name: non-Hodgkin lymphoma


subject: CHEBI:6427

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:6427

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:6427

object_name: Hodgkin Disease


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Consciousness Disorders


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEMBL.COMPOUND:CHEMBL5095317

object_name: autoimmune hemolytic anemia


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: ST-elevation myocardial infarction


subject: UNII:LKC0U3A8NJ

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:15379

subject_name: Oxygen

object_name: Postoperative atelectasis


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Plasma cell myeloma refractory


subject: CHEBI:2038

subject_name: Azacitidine


subject: UMLS:C0456388

subject_name: Blood product

object_name: postpartum hemorrhage


subject: UMLS:C0456388

object_name: Post-partum hemorrhage


subject: PUBCHEM.COMPOUND:53395107

subject_name: Duratocin


subject: PUBCHEM.COMPOUND:53395107


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Post procedural infection


subject: CHEBI:83766

subject_name: Olaparib

object_name: invasive breast carcinoma


subject: CHEBI:83766

object_name: RAD51 Gene Mutation


subject: CHEBI:83766

object_name: NBN Gene Mutation


subject: CHEBI:83766

object_name: BRIP1 Gene Mutation


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0384570

object_name: obesity


subject: UMLS:C0384570

object_name: Obesity, CTCAE


subject: UMLS:C1170447

subject_name: NovoLog Mix 70/30

object_name: type 1 diabetes mellitus


subject: MESH:C492793

subject_name: Shen-Fu

object_name: Sepsis


subject: MESH:C492793

object_name: Sepsis, CTCAE


subject: CHEBI:29958

subject_name: L-aspartic acid residue

object_name: malaria


subject: CHEBI:22660

subject_name: aspartic acid


subject: CHEBI:74557

subject_name: Lys-Glu

object_name: type 2 diabetes mellitus


subject: CHEBI:74557

object_name: systolic heart failure


subject: PUBCHEM.COMPOUND:49863420

subject_name: ceftolozane

object_name: leukopenia


subject: PUBCHEM.COMPOUND:49863420

object_name: neutropenia


subject: CHEBI:9421

subject_name: Tazobactam


subject: CHEBI:9421


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: Renal transplant rejection


subject: UMLS:C1709429


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Metastatic Cutaneous Melanoma


subject: GTOPDB:12990

object_name: Unresectable Cutaneous Melanoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C5238976

subject_name: Negalstobart


subject: UMLS:C5238976


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: female reproductive organ cancer


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:25MKH1SZ0M

object_name: lymphatic malformation


subject: UNII:25MKH1SZ0M

object_name: Congenital lymphatic malformation


subject: PUBCHEM.COMPOUND:353481

subject_name: Nikkomycin

object_name: coccidioidomycosis


subject: CHEBI:623918

subject_name: Nikkomycin Z


subject: UMLS:C0068758

subject_name: nikkomycin


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: colorectal neoplasm


subject: CHEBI:25805

subject_name: oxygen atom

object_name: brain hypoxia


subject: CHEBI:25805

object_name: neurobehavioral manifestations


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: UMLS:C3827103

object_name: Clear-cell metastatic renal cell carcinoma


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:3249

object_name: Chronic uremia


subject: UMLS:C3714696

subject_name: Ergocalciferol Drug Product


subject: UMLS:C3714696


subject: CHEBI:87681

subject_name: Ranolazine

object_name: Recurrence


subject: CHEBI:87681

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:87681

object_name: Recurrent disease


subject: CHEBI:87681

object_name: Recurrent tumor


subject: CHEBI:42797

subject_name: Gabapentin

object_name: lung disorder


subject: CHEBI:42797

object_name: History of - respiratory disease


subject: CHEBI:42797

object_name: Dissecting Thoracic Aortic Aneurysm


subject: CHEBI:59265

subject_name: palmitelaidic acid

object_name: Prediabetes


subject: CHEBI:59265

object_name: Overweight


subject: CHEBI:59265

object_name: type 2 diabetes mellitus


subject: CHEBI:59265

object_name: Insulin resistance


subject: CHEBI:59265

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:59265

object_name: obesity


subject: CHEBI:59265

object_name: Obesity, CTCAE


subject: CHEBI:28716

subject_name: Palmitoleic Acid


subject: CHEBI:28716


subject: CHEBI:28716


subject: CHEBI:28716


subject: CHEBI:28716


subject: CHEBI:28716


subject: CHEBI:28716


subject: CHEBI:23965

subject_name: estradiol

object_name: prostate carcinoma


subject: CHEBI:23965

object_name: prostate cancer


subject: CHEBI:23965

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:23965

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:23965

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:23965

object_name: Cardiac complication


subject: CHEBI:23965

object_name: anemia


subject: CHEBI:23965

object_name: Anemia, CTCAE


subject: UNII:3H8GSZ4SQL

subject_name: Avatrombopag

object_name: Acute-On-Chronic Liver Failure


subject: UNII:3H8GSZ4SQL

object_name: acute-on-chronic liver failure


subject: UNII:3H8GSZ4SQL

object_name: chronic hepatitis B virus infection


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: bone marrow failure syndrome


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UNII:3H8GSZ4SQL

object_name: liver failure


subject: UNII:3H8GSZ4SQL

object_name: Decompensated cirrhosis of liver


subject: CHEBI:73044

subject_name: Lumiracoxib

object_name: osteoarthritis, knee


subject: MESH:D056692

subject_name: Prebiotics

object_name: irritable bowel syndrome


subject: CHEBI:45783

subject_name: Imatinib

object_name: head and neck squamous cell carcinoma


subject: CHEBI:16958

subject_name: beta-Alanine

object_name: multiple sclerosis


subject: UMLS:C0000392

subject_name: beta-alanine


subject: CHEBI:31401

subject_name: Cilostazol

object_name: mild neurocognitive disorder


subject: CHEBI:31401

object_name: mild cognitive impairment


subject: CHEMBL.COMPOUND:CHEMBL2109526


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:16467

subject_name: Arginine

object_name: Muscle Fatigue


subject: CHEBI:8364

subject_name: Prazosin

object_name: bulimia nervosa


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: urticaria


subject: CHEBI:89324

object_name: reported urticaria (physical finding)


subject: CHEBI:89324

object_name: Urticaria, CTCAE


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: GTOPDB:8270

subject_name: cenersen

object_name: Myelodysplasia


subject: UNII:K6KJ8AZ05F

subject_name: CENERSEN


subject: UMLS:C4727145

object_name: Adult Solid Neoplasm


subject: UMLS:C4727145

object_name: carcinoma of esophagus


subject: UMLS:C4727145

object_name: esophageal cancer


subject: UMLS:C4727145

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C4727145

object_name: neoplasm of esophagus


subject: UMLS:C4727145

object_name: Neck Carcinoma


subject: UMLS:C4727145

object_name: head and neck neoplasm


subject: UMLS:C4727145

object_name: head and neck cancer


subject: UMLS:C4727145

object_name: diffuse large B-cell lymphoma


subject: UMLS:C4727145

object_name: non-small cell lung carcinoma


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: UMLS:C2987409

object_name: acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:66621102

object_name: Indolent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:66621102

object_name: Indolent lymphoma


subject: CHEBI:85089

subject_name: Ledipasvir


subject: CHEBI:85089


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: CHEBI:85083


subject: CHEBI:3756

subject_name: Clonazepam

object_name: REM sleep behavior disorder


subject: CHEBI:173081

subject_name: copanlisib dihydrochloride

object_name: Recurrent Platinum-Resistant Primary Peritoneal Carcinoma


subject: CHEBI:173081

object_name: Recurrent Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:173081

object_name: Recurrent Platinum-Resistant Fallopian Tube Carcinoma


subject: CHEBI:173081

object_name: Platinum-Refractory Primary Peritoneal Carcinoma


subject: CHEBI:173081

object_name: Recurrent Primary Peritoneal Endometrioid Adenocarcinoma


subject: CHEBI:173081

object_name: Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:173081

object_name: Recurrent Fallopian Tube Endometrioid Adenocarcinoma


subject: CHEBI:173081

object_name: Platinum-Refractory Fallopian Tube Carcinoma


subject: CHEBI:173081

object_name: Recurrent Ovarian Endometrioid Adenocarcinoma


subject: CHEBI:173081

object_name: Recurrent Fallopian Tube High Grade Serous Adenocarcinoma


subject: CHEBI:173081

object_name: Recurrent Ovarian High Grade Serous Adenocarcinoma


subject: CHEBI:173081

object_name: Platinum-Refractory Ovarian Carcinoma


subject: UMLS:C4528197

subject_name: Copanlisib dihydrochloride


subject: UMLS:C4528197


subject: UMLS:C4528197


subject: UMLS:C4528197


subject: UMLS:C4528197


subject: UMLS:C4528197


subject: UMLS:C4528197


subject: UMLS:C4528197


subject: UMLS:C4528197


subject: UMLS:C4528197


subject: UMLS:C4528197


subject: UMLS:C4528197


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: UMLS:C5959037

subject_name: KRAS G12C Inhibitor BBO-8520


subject: UMLS:C5959037

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C5959037

object_name: non-small cell lung carcinoma


subject: UMLS:C5959037

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C5959037

object_name: Advanced Lung Carcinoma


subject: CHEBI:337298

subject_name: Abarelix

object_name: prostate carcinoma


subject: CHEBI:337298

object_name: prostate cancer


subject: UMLS:C0965389


subject: UMLS:C0965389


subject: PUBCHEM.COMPOUND:121362450

object_name: kidney failure


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: Post-Operative Pain


subject: CHEBI:17925

object_name: Inguinal hernia


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:32250

subject_name: tramadol hydrochloride


subject: CHEBI:75722

subject_name: Tramadol


subject: UMLS:C0032375

subject_name: Oral Poliovirus Vaccine

object_name: enterovirus infectious disease


subject: UMLS:C0032375

object_name: type 1 diabetes mellitus


subject: UMLS:C0032375

object_name: Prediabetes


subject: CHEBI:75551

object_name: wet macular degeneration


subject: CHEBI:36333

subject_name: local anaesthetic

object_name: neuralgia


subject: CHEBI:36333

object_name: Chronic pain


subject: CHEBI:36333

object_name: Acute Pain


subject: CHEBI:36333

object_name: pain agnosia


subject: CHEBI:36333

object_name: Pain insensitivity


subject: UMLS:C3536836

subject_name: Local Anesthetic [EPC]


subject: UMLS:C3536836


subject: UMLS:C3536836


subject: UMLS:C3536836


subject: UMLS:C3536836


subject: UMLS:C5787285

subject_name: EGFR Tri-specific Natural Killer Cell Engager DF9001

object_name: Adult Solid Neoplasm


subject: CHEBI:29287

subject_name: Gold

object_name: poliomyelitis


subject: CHEBI:29287

object_name: diphtheria


subject: CHEBI:29287

object_name: pertussis


subject: CHEBI:29287

object_name: tetanus


subject: MESH:D011054

subject_name: Poliovirus Vaccine, Inactivated


subject: CHEBI:167638

subject_name: Labetalol

object_name: Peripheral perfusion


subject: CHEBI:167638

object_name: Post-Operative Pain


subject: UMLS:C5203528

subject_name: Magnesium Sulfate Liquid Injection


subject: CHEBI:32599


subject: UMLS:C0717762

subject_name: Ethinyl Estradiol / norgestimate

object_name: Congenital, Hereditary, and Neonatal Diseases and Abnormalities


subject: UMLS:C0717762

object_name: central nervous system malformation


subject: UMLS:C0717762

object_name: congenital nervous system disorder


subject: UMLS:C0717762

object_name: neural tube defect


subject: UMLS:C0717762

object_name: neural tube defects, susceptibility to


subject: PUBCHEM.COMPOUND:9909681

subject_name: lasofoxifene

object_name: osteoporosis


subject: PUBCHEM.COMPOUND:9909681

object_name: Encounter due to family history of osteoporosis


subject: PUBCHEM.COMPOUND:9909681

object_name: Osteoporosis, CTCAE 5.0


subject: PUBCHEM.COMPOUND:9909681

object_name: Osteoporosis, CTCAE 3.0


subject: CHEMBL.COMPOUND:CHEMBL2108465

subject_name: GINGER

object_name: post operative nausea and vomiting


subject: UNII:C5529G5JPQ

subject_name: ginger extract


subject: CHEBI:30884

subject_name: glycoloyl group

object_name: EXCESS LMW-DNA


subject: CHEBI:73890

subject_name: Gly-Cys


subject: CHEBI:34967

subject_name: Rimonabant

object_name: inherited lipid metabolism disorder


subject: CHEBI:34967

object_name: Dyslipidemia


subject: UMLS:C1174273


subject: UMLS:C1174273


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: Chemotherapy induced neutropenia


subject: CHEBI:75179

subject_name: Trifluridine


subject: CHEBI:75179

object_name: esophageal adenocarcinoma


subject: CHEBI:90879

subject_name: Tipiracil


subject: CHEBI:90879


subject: MESH:D020355

subject_name: Cholates

object_name: chronic liver failure


subject: DRUGBANK:DB16198

object_name: obesity due to melanocortin 4 receptor deficiency


subject: DRUGBANK:DB16198

object_name: obesity


subject: DRUGBANK:DB16198

object_name: Obesity, CTCAE


subject: UMLS:C2959235

subject_name: Injection, canakinumab, 1 mg administered

object_name: anemia


subject: UMLS:C2959235

object_name: Anemia, CTCAE


subject: UMLS:C5203516

subject_name: Canakinumab Liquid Injection


subject: UMLS:C5203516


subject: UNII:37CQ2C7X93

subject_name: Canakinumab


subject: UNII:37CQ2C7X93


subject: UMLS:C1872514

subject_name: talactoferrin alfa

object_name: non-small cell lung carcinoma


subject: CHEBI:151315

subject_name: Heparin

object_name: blood coagulation disease


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: UNII:5Y869C2THE

object_name: osteoarthritis, knee


subject: MESH:C469818


subject: UMLS:C2609633

subject_name: Divalproex Sodium ER

object_name: schizophrenia


subject: UMLS:C2609633

object_name: epilepsy


subject: UMLS:C4058551

subject_name: Paliperidone ER


subject: HMDB:HMDB0248508

subject_name: Apelin

object_name: Diabetes


subject: HMDB:HMDB0248508

object_name: diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL4650373

subject_name: APELIN


subject: CHEMBL.COMPOUND:CHEMBL4650373


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: Anesthetics adverse reaction


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C3493541

subject_name: AMG 853

object_name: asthma


subject: UMLS:C0002525

subject_name: Amino Acids, Essential

object_name: Paresis


subject: UMLS:C0002525

object_name: Muscle weakness


subject: UMLS:C0002525

object_name: Muscle Atrophy


subject: MESH:C520497

subject_name: MoviPrep

object_name: autism spectrum disorder


subject: MESH:C520497

object_name: Gastrointestinal problem


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:125535

subject_name: Esreboxetine

object_name: amphetamine abuse


subject: CHEBI:125535

object_name: substance-related disorder


subject: CHEBI:125535

object_name: mood disorder


subject: CHEBI:135342

subject_name: Reboxetine


subject: CHEBI:135342


subject: CHEBI:135342


subject: UMLS:C1134622

object_name: Embolism, Tumor


subject: UMLS:C1134622

object_name: Neoplasm Metastasis


subject: UMLS:C1134622

object_name: Metastatic Lesion


subject: UMLS:C1134622

object_name: colorectal carcinoma


subject: KEGG.COMPOUND:C00735

subject_name: Cortisol

object_name: post-traumatic stress disorder


subject: UMLS:C4764994

subject_name: Imiglucerase for Injection

object_name: Gaucher disease type I


subject: UMLS:C4764994

object_name: Gaucher disease


subject: HMDB:HMDB0015179

subject_name: Rifampin

object_name: Uses contraception (finding)


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: spinal stenosis


subject: UMLS:C1250042

object_name: Spinal stenosis of thoracic region


subject: UMLS:C1250042

object_name: lumbar spinal stenosis


subject: UMLS:C1250042

object_name: Femoral head necrosis


subject: UMLS:C1250042

object_name: Rotator Cuff Injuries


subject: UMLS:C1250042

object_name: Rotator Cuff Injury, CTCAE


subject: UNII:3P4CR02JTD

object_name: chronic obstructive pulmonary disease


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: malignant testicular germ cell tumor


subject: CHEBI:175901

object_name: neoplasm of testis


subject: CHEBI:175901

object_name: testicular cancer


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C3827169

object_name: acute myeloid leukemia


subject: UMLS:C3827168


subject: CHEBI:50853

subject_name: quantum dot

object_name: urothelial carcinoma


subject: CHEBI:50853

object_name: transitional cell carcinoma


subject: UMLS:C4763757

subject_name: Erfonrilimab

object_name: adult lymphoma


subject: UMLS:C4763757

object_name: lymphoma


subject: UMLS:C4763757

object_name: pediatric lymphoma


subject: UNII:WJA5UO9E10

subject_name: Orelabrutinib

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:WJA5UO9E10

object_name: B-cell neoplasm


subject: UNII:WJA5UO9E10

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:WJA5UO9E10

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:WJA5UO9E10

object_name: High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:WJA5UO9E10

object_name: high grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement


subject: UNII:M67G28K74K

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UNII:M67G28K74K

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C4733318

object_name: Breakthrough cancer pain


subject: UNII:4ADT8JXB9S

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UMLS:C4045791


subject: MESH:C518246

subject_name: Lymphomyosot

object_name: Bone fracture


subject: MESH:C518246

object_name: Fracture, CTCAE


subject: MESH:C518246

object_name: ankle injury


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: pseudomyxoma peritonei


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: non-small cell lung carcinoma


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UNII:JWF5YAW3QW

subject_name: Valerian

object_name: sleep disorder


subject: UNII:JWF5YAW3QW

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:JWF5YAW3QW

object_name: Fatigue, CTCAE 5.0


subject: UNII:JWF5YAW3QW

object_name: Fatigue


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Melasma


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: CHEBI:16204

subject_name: Phloroglucinol

object_name: Birthing Labor


subject: CHEBI:140754

subject_name: Quinonoid 7,8-Tetrahydrobiopterin


subject: UMLS:C0003438

subject_name: antithrombin III

object_name: congenital alveolar dysplasia


subject: UMLS:C0003438

object_name: severe acute respiratory syndrome


subject: UMLS:C0723738

subject_name: Thrombate III


subject: UMLS:C0723738


subject: UMLS:C0003440

subject_name: Antithrombins


subject: UMLS:C0003440


subject: UMLS:C0003440


subject: UMLS:C4310525

object_name: Leber congenital amaurosis


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion

object_name: Adherence To Medication Regime


subject: CHEBI:3001

subject_name: beclomethasone


subject: RXCUI:1790637

subject_name: formoterol / glycopyrronium Metered Dose Inhaler

object_name: Chronic obstructive pulmonary disease of horses


subject: RXCUI:1790637

object_name: COPD, severe early onset


subject: RXCUI:1790637


subject: CHEBI:2639

subject_name: Amiloride

object_name: Moderate albuminuria


subject: UNII:O8M467C50G

subject_name: Vesatolimod

object_name: chronic hepatitis B virus infection


subject: UNII:O8M467C50G

object_name: hepatitis B


subject: CHEBI:71464

subject_name: Palmidrol

object_name: knee fracture


subject: CHEBI:71464

object_name: fibula fracture


subject: CHEBI:71464

object_name: Fractured tibia


subject: MESH:D010919

subject_name: Placebos

object_name: hepatitis C


subject: CHEMBL.COMPOUND:CHEMBL55643

subject_name: COPPER

object_name: glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL55643

object_name: Brain Stem Glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL55643

object_name: glioma susceptibility 1


subject: CHEBI:28694

subject_name: Copper


subject: CHEBI:28694


subject: CHEBI:28694


subject: CHEBI:29036

subject_name: Cupric cation


subject: CHEBI:29036


subject: CHEBI:29036


subject: CHEBI:4356

subject_name: Deferoxamine

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: PUBCHEM.COMPOUND:4087

object_name: cesarean section; complications